However, previous clinical studies demonstrated that LY6K (a human orthologue of murine Ly6k) is expressed in cancer cells of some patients with non-small cell lung carcinoma or oesophageal squamous cell carcinoma, as a new member of the cancer-testis antigens12, 13. Here, LY6K is linked to cancer.